Search research articles
Contact Us
Filters
Showing results (101-110 of 1,129) with videos related to
Page
of 113
Sort By:
North Carolina Medical Journal
|
September 1, 2019
More Than Health Care Services: North Carolina's Focus on Improving Whole-person Health and Patient Experience
Karen E Michael
Nursing Management
|
June 7, 2002
DNR orders: proceed with caution
Janet E Michael
Journal of Muscle Research and Cell Motility
|
March 13, 2003
2,3-Butanedione monoxime (BDM) as a myosin inhibitor
E Michael Ostap
Home Healthcare Nurse
|
August 15, 2003
What home healthcare nurses should know about fraud and abuse
Janet E Michael
Expert Opinion on Investigational Drugs
|
October 10, 2007
Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis
E Michael Lewiecki
Chemosphere
|
June 10, 2006
"Does atrazine transform to propazine in aquatic sediments?": Comment on "biological and chemical transformations of atrazine in coastal aquatic sediments" by Kelly L. Smalling and C. Marjorie Aelion [Chemosphere 62 (2006) 188-196]
E Michael Thurman
Social Science & Medicine (1982)
|
February 20, 2010
Medicaid and racial disparities in health: the issue of causality. A commentary on Rose et al
E Michael Foster
Expert Opinion on Biological Therapy
|
January 26, 2010
Denosumab--an emerging treatment for postmenopausal osteoporosis
E Michael Lewiecki
Advances in Experimental Medicine and Biology
|
February 13, 2009
Tropomyosins as discriminators of myosin function
E Michael Ostap
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
September 2, 2008
A clinician's perspective on the use of zoledronic acid in the treatment of postmenopausal osteoporosis
E Michael Lewiecki
Page
of 113
Search research articles
Search
Showing results (101-110 of 1,129) with videos related to
Sort By:
Page
of 113
North Carolina Medical Journal
|
September 1, 2019
More Than Health Care Services: North Carolina's Focus on Improving Whole-person Health and Patient Experience
Karen E Michael
Nursing Management
|
June 7, 2002
DNR orders: proceed with caution
Janet E Michael
Journal of Muscle Research and Cell Motility
|
March 13, 2003
2,3-Butanedione monoxime (BDM) as a myosin inhibitor
E Michael Ostap
Home Healthcare Nurse
|
August 15, 2003
What home healthcare nurses should know about fraud and abuse
Janet E Michael
Expert Opinion on Investigational Drugs
|
October 10, 2007
Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis
E Michael Lewiecki
Chemosphere
|
June 10, 2006
"Does atrazine transform to propazine in aquatic sediments?": Comment on "biological and chemical transformations of atrazine in coastal aquatic sediments" by Kelly L. Smalling and C. Marjorie Aelion [Chemosphere 62 (2006) 188-196]
E Michael Thurman
Social Science & Medicine (1982)
|
February 20, 2010
Medicaid and racial disparities in health: the issue of causality. A commentary on Rose et al
E Michael Foster
Expert Opinion on Biological Therapy
|
January 26, 2010
Denosumab--an emerging treatment for postmenopausal osteoporosis
E Michael Lewiecki
Advances in Experimental Medicine and Biology
|
February 13, 2009
Tropomyosins as discriminators of myosin function
E Michael Ostap
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
September 2, 2008
A clinician's perspective on the use of zoledronic acid in the treatment of postmenopausal osteoporosis
E Michael Lewiecki
Page
of 113